As a member of the pharmacokinetics team, you are responsible for the design and interpretation of efficient and informative Phase I trials. In preclinical studies, you interpret toxicokinetic data, and via physiological modeling and allometric scaling, you extrapolate results from animal to man. During early clinical testing, you aid in the interpretation of dose-response and dose escalation studies.
Pharsight®’s industry standard tools free you from manual performance of routine tasks; provide data in a streamlined yet regulatory-compliant workflow; and support quantitative decision-making. The results include more informative trials and higher productivity.
Pharsight is the established leader for strategic drug development consulting, analytical modeling tools, drug attribute visualization, and PK/PD data management.
A global team of scientific experts with a focus on using quantitative models to improve drug development strategy and decision-making.
Benefits
WinNonlin — Industry-standard
PK/PD modeling, analysis and simulation tool.
WinNonlin Validation Suite™ — Streamlines your on-site validation of WinNonlin.
IVIVC Toolkit™ for WinNonlin—Enables the use of WinNonlin for in-vitro / in-vivo correlations.
WinNonMix® — Population PK/PD modeling and simulation tool.
Trial Simulator™ — Computer assisted clinical trial design and simulation
software.
Benefits
Pharsight Knowledgebase Server™ (PKS™) — Enterprise
data management system for secure storage and change tracking for PK/PD
data and analyses.
PKS Reporter™ — Automated system for report authoring, updating, and
review/approval.
WinNonlin® AutoPilot™— Software application for WinNonlin that automates creation of clinical PK analysis outputs for standard reports.
Benefits
Drug Model Explorer® (DMX®) — Visualization and communication tool to explore and compare model-based product profiles.
Benefits
"SAS and all other SAS Institute Inc. product or service names are registered trademarks or trademarks of SAS Institute Inc. in the USA and other countries. ®indicates USA registration."